by Neoteryx | 3 min read
Local governments and states have implemented restrictions to reduce transmission of the deadly coronavirus known as SARS-CoV-2, which causes COVID-19 illness. Their early efforts paid off; the curve flattened in …
Read Storyby Neoteryx | 3 min read
The invention of new drugs relies on the ability to test and validate the research. It hasn’t exactly been smooth sailing in recent years. In fact, it’s been notoriously difficult for …
Read Storyby Neoteryx | 1 min read
When Fasha Mahjoor launched Neoteryx, he planned to change the way dried capillary blood is collected, to become the most significant blood microsampling innovator in the modern marketplace. In that, …
Read Storyby Neoteryx | 2 min read
In an era of change, labs are responding with new and innovative approaches and considering new angles from science and business perspectives. One Austin-based lab, focused on personalized medicine, merits …
Read Storyby Neoteryx | 2 min read
The California Initiative for the Advancement of Precision Medicine (CIAPM) is a national public entity formulated to ignite rational precision medicine research on popular diseases. It recently funded a study …
Read Storyby Neoteryx | 1 min read
Laboratories: It’s time to get off the reimbursement treadmill. You’ll expand your test menu and open your options when you add remote biofluid collection to your toolkit. At Neoteryx, we …
Read Story